The primary role of the TAS is to drive demand for BMS medicines within their portfolio for the appropriate patients.
Base: $134,390 - $162,843; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Work-life benefits
Must-have
Nice-to-have
Not specified